Managing diabetes in hemodialysis patients: observations and recommendations.
Diabetes is challenging to manage in patients who have end-stage renal disease (ESRD), as both uremia and dialysis can complicate glycemic control by affecting the secretion, clearance, and peripheral tissue sensitivity of insulin. The authors summarize the available evidence and make practical recommendations.
Shrishrimal
Kumarpal
K
Department of Hospital Medicine, Cleveland Clinic, Cleveland, OH 44195, USA. shrishk@ccf.org
Hart
Peter
P
Michota
Franklin
F
D001786:Blood Glucose / Q000378:metabolism; D000075202:Contraindications; D003920:Diabetes Mellitus / Q000628:therapy*; D015314:Dialysis Solutions / Q000009:adverse effects / Q000737:chemistry; D005947:Glucose / Q000009:adverse effects; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000145:classification / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism / Q000627:therapeutic use; D000078790:Insulin Secretion; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000628:therapy; D006435:Renal Dialysis / Q000009:adverse effects*; D014511:Uremia / Q000150:complications
D001786:Blood Glucose; D015314:Dialysis Solutions; D005947:Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin